Home Industries Health Services Team approach allows Amgen to complete new biomanufacturing plant in 2020

Team approach allows Amgen to complete new biomanufacturing plant in 2020

CLOSE EYE: From left, associate manufacturer Adeline Lamothe, manufacturing process technician contract worker Austin White and associate manufacturer David Folco check the single-use bioreactors, which are used to control the conditions for generating protein cells at Amgen Rhode Island in West Greenwich. / COURTESY AMGEN INC.
CLOSE EYE: From left, associate manufacturer Adeline Lamothe, manufacturing process technician contract worker Austin White and associate manufacturer David Folco check the single-use bioreactors, which are used to control the conditions for generating protein cells at Amgen Rhode Island in West Greenwich. / COURTESY AMGEN INC.

PBN Manufacturing Awards 2021 Overall Excellence at an Enterprise Manufacturer: Amgen Rhode Island Amgen Inc. develops medications for oncology/hematology, cardiovascular disease, inflammation, bone health, nephrology and neuroscience conditions for which treatment options are often limited. The company has invested more than $1.5 billion in its 75-acre Amgen Rhode Island complex in West Greenwich, including just

Already a Subscriber? Log in

To Continue Reading This Article

Become a Providence Business News subscriber and get immediate access to all of our premier content and much more.

Learn More and Become a Subscriber
  • Critical RI business news and analysis updated daily.
  • 1 year of print (26 issues).
  • Unlimited access to all subscriber only content on our website, on any device.
  • Free email alerts.
  • Annual Book of Lists Print Edition.
  • All special issues produced during subscription term.

RELATED ARTICLES

NO COMMENTS

Copyright ©2026 Providence Business News. All Rights Reserved.
Exit mobile version